CYMHF (Cymat Technologies) Debt-to-EBITDA : -3.08 (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CYMHF Cymat Technologies Ltd CYMHF
14 GF Score
Price $0.07
GF Value $0.04
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Cymat Technologies Debt-to-EBITDA?

Cymat Technologies CYMHF 14 Debt-to-EBITDA is -3.08 as of Jan. 2026. GuruFocus rates CYMHF with a GF Score™ of 14/100 and a GF Value™ of $0.04 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 2,348 Industrial Products companies, Cymat Technologies ranks worse than 42589.4% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cymat Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2026 was $3.39 Mil. Cymat Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2026 was $1.02 Mil. Cymat Technologies's annualized EBITDA for the quarter that ended in Jan. 2026 was $-1.43 Mil. Cymat Technologies's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2026 was -3.08.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Cymat Technologies's Debt-to-EBITDA or its related term are showing as below:

CYMHF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -14.75   Med: -0.91   Max: 4.36
Current: -2.2

During the past 13 years, the highest Debt-to-EBITDA Ratio of Cymat Technologies was 4.36. The lowest was -14.75. And the median was -0.91.

CYMHF's Debt-to-EBITDA is ranked worse than
100% of 2348 companies
in the Industrial Products industry
Industry Median: 1.68 vs CYMHF: -2.20

Cymat Technologies  (OTCPK:CYMHF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Cymat Technologies Debt-to-EBITDA Related Terms


Cymat Technologies Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Cymat Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cymat Technologies Debt-to-EBITDA Chart

Cymat Technologies Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.35 -0.24 -0.42 -1.12 -2.92

Cymat Technologies Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.66 -1.62 -1.97 -2.16 -3.08

CYMHF vs CRS, ATI, MLI: Debt-to-EBITDA Comparison

For the Metal Fabrication subindustry, Cymat Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cymat Technologies Debt-to-EBITDA vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Cymat Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cymat Technologies's Debt-to-EBITDA falls into.


CYMHF
14GF Score
Cymat Technologies Ltd CYMHF
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cymat Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cymat Technologies's Debt-to-EBITDA for the fiscal year that ended in Apr. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.731 + 1.262) / -1.368
=-2.92

Cymat Technologies's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.386 + 1.017) / -1.428
=-3.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -3.08 mean?
Cymat Technologies (CYMHF) has a Debt-to-EBITDA of -3.08 as of Jan. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Cymat Technologies. According to the industry distribution chart, Cymat Technologies ranks #999999 out of 2348 companies in the Industrial Products industry.
Is Cymat Technologies' Debt-to-EBITDA too high?
Cymat Technologies' current Debt-to-EBITDA is -3.08. Based on the distribution chart, Cymat Technologies ranks #999999 out of 2348 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Cymat Technologies has a GF Score™ of 14/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cymat Technologies' Debt-to-EBITDA compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Cymat Technologies ranks #999999 out of 2348 companies for Debt-to-EBITDA. This places Cymat Technologies in the lower half of its industry. The industry median Debt-to-EBITDA is 1.68. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for an Industrial Products company?
The median Debt-to-EBITDA among Industrial Products companies is 1.68, based on 2,348 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Cymat Technologies. For the Industrial Products industry, the median Debt-to-EBITDA is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cymat Technologies's current Debt-to-EBITDA is -3.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cymat Technologies stock overvalued right now?
Based on GuruFocus' analysis, Cymat Technologies (CYMHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.04, compared to a current price of $0.07 — trading 81.3% above its estimated fair value. The current Debt-to-EBITDA is -3.08. Cymat Technologies' overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Cymat Technologies (CYMHF), the current Debt-to-EBITDA is -3.08 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cymat Technologies (CYMHF) Overvalued in 2026?

Based on GuruFocus' analysis, Cymat Technologies stock appears to be overvalued. The current stock price of $0.07 is trading 81.3% above its estimated GF Value™ of $0.04. GuruFocus considers Cymat Technologies to be Significantly Overvalued.

Key valuation signals for CYMHF:

  • Debt-to-EBITDA: -3.08
  • GF Value™: $0.04 vs. price of $0.07 (81.3% above fair value)
  • GF Score™: 14/100 with 4 warning signs

No single metric tells the full story. See the CYMHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cymat Technologies Business Description

Other Exchanges CYM:Canada
Address 6320 Danville Road, Unit 2, Mississauga, ON, CAN, L5T 2L7
Cymat Technologies Ltd is a materials technology company that manufactures and sells stabilized aluminum foam (SAF) products to various countries. Its proprietary technology produces lightweight, porous aluminum foam that offers energy absorption, thermal and acoustic insulation, and blast mitigation. Its products are used in the automotive and industrial markets. Cymat serves automotive, architecture, defense, and general industrial sectors by providing customizable aluminum foam solutions. Revenue arises mainly from the sale of SAF based on customer contracts. Geographically Europe and UK generates majority of its revenue.
14GF Score

Get the complete analysis for CYMHF

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price
$0.04
GF Value